Combined Targeting of G9a and Checkpoint kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse

Due to its dismal outcome, pancreatic cancer (PDAC) remains a therapeutic challenge making the testing of new pharmacological tools a goal of paramount importance. Here, we developed a rational approach for inhibiting PDAC growth based on leveraging cell cycle arrest of malignant cells at a phase th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Res
Main Authors: Urrutia, Guillermo, Salmonson, Ann, Toro-Zapata, Jorge, de Assuncao, Thiago M., Mathison, Angela, Dusetti, Nelson, Iovanna, Juan, Urrutia, Raul, Lomberk, Gwen
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056528/
https://ncbi.nlm.nih.gov/pubmed/31822519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0490
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados